We previously reported preliminary results of association of clozapine
-induced agranulocytosis (CA) with HLA-B38, DR4, DQ3 in five Ashkenazi
Jewish patients and with HLA-DR2, DQ1 in four non-Jewish patients. In
the present study, 31 additional patients with CA, 10 Ashkenazi Jewis
h, and 21 of non-Jewish ancestry, were studied. HLA alleles and haplot
ypes were compared among 52 patients (33 Ashkenazi Jewish, 19 non-Jewi
sh) matched for ethnic background and clinical status. Our results sho
w two associations and define the HLA allele markers for the Ashkenazi
Jewish and non-Jewish haplotypes associated with CA. The most importa
nt markers for susceptibility for CA in Ashkenazi Jewish patients were
DRB10402, DQB1*0302, and DQA1*0301, and in non-Jewish patients, HLA-
DR02, DQB1*0502, and DQA1*0102. HLA-DRB1*011 and DQB1*0301 were under
represented in Ashkenazi Jewish patients when compared with controls.
We hypothesize that genes of the major histocompatability complex, oth
er than class I and class II, are responsible for CA; among them are t
he variants of the heat-shock proteins 70 or the tumor necrosis factor
loci. (C) 1995 by The American Society of Hematology.